Junshi Biosciences Announces Approval of Toripalimab NDA for the 1st-line treatment of HER2 Expressing Urothelial Carcinoma
Notified -
&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif;
2026-05-21, 17:28
Email: info@10toptenreviews.com
10 Top Ten Reviews is part of VSG Solution JSC, an international media group and leading digital publisher.
© 2021 - 10TopTenReiews All Rights Reserved.